and their pharmaceutically acceptable salts wherein Aryl represents phenyl group substituted with a group chosen from isopropyl, acetyl, (2'',6''-dichlorophenyl)amino-group, -hydroxyisopropyl, (R,S)--hydroxybenzyl and its individual R-isomers, (R,S)-(-methylbenzyl) and its individual R-isomer and (R,S)--hydroxy--methylbenzyl and its individual R-isomer; R represents hydrogen atom (H) or (C1-C4)-alkyl; R' represents the following groups: -amino acid residue consisting of linear or branched (C1-C6)-alkyl substituted with carboxy-group -CO2H; -residue of the formula: -CH2-CH2X-(CH2-CH2O)nR wherein R has abovementioned values; n means a whole number from 0 to 1 while X represents oxygen atom; -heteroaryl chosen from the group consisting of 2-pyrimidinyl or 4-pyrimidinyl. Also, invention proposes a pharmaceutical composition inhibiting of interleukin-8-induced chemotaxis of neutrophiles and comprising as an active components (R)-enantiomers of 2-arylpropionamides of the formula (I) and their pharmaceutically acceptable salts in mixture with a suitable carrier. Also, invention proposes a method for preparing compounds of the formula (Ia). Also, invention proposes (R)-enantiomers of 2-arylpropionic acids of the formula (Va) given in the invention description and their pharmaceutically acceptable salts. Proposed (R)-2-arylpropionamides are useful in prophylaxis and treatment of tissue damage caused by enhanced accumulation of polymorphonuclear neutrophiles in the inflammation sites.;EFFECT: improved preparing method, valuable medicinal properties of compounds and composition.;13 cl, 6 tbl, 24 ex"/> (R)-2-ARYLPROPIONAMIDES USEFUL IN INHIBITION OF IL-8-INDUCED CHEMOTAXIS OF NEUTROPHILES, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION INHIBITING INTERLEUKIN-8-INDUCED CHEMOTAXIS OF NEUTROPHILES
首页> 外国专利> (R)-2-ARYLPROPIONAMIDES USEFUL IN INHIBITION OF IL-8-INDUCED CHEMOTAXIS OF NEUTROPHILES, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION INHIBITING INTERLEUKIN-8-INDUCED CHEMOTAXIS OF NEUTROPHILES

(R)-2-ARYLPROPIONAMIDES USEFUL IN INHIBITION OF IL-8-INDUCED CHEMOTAXIS OF NEUTROPHILES, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION INHIBITING INTERLEUKIN-8-INDUCED CHEMOTAXIS OF NEUTROPHILES

机译:(R)-2-芳基丙酰胺类化合物,其用于抑制IL-8诱导的中性粒细胞趋化性,制备其的方法和中间化合物,抑制其介导的IL-8的中性化合物的药物成分

摘要

FIELD: organic chemistry, biochemistry, medicine, pharmacy.;SUBSTANCE: invention relates to (R)-enantiomers of 2-arylpropionamides of the formula (Ia): and their pharmaceutically acceptable salts wherein Aryl represents phenyl group substituted with a group chosen from isopropyl, acetyl, (2'',6''-dichlorophenyl)amino-group, -hydroxyisopropyl, (R,S)--hydroxybenzyl and its individual R-isomers, (R,S)-(-methylbenzyl) and its individual R-isomer and (R,S)--hydroxy--methylbenzyl and its individual R-isomer; R represents hydrogen atom (H) or (C1-C4)-alkyl; R' represents the following groups: -amino acid residue consisting of linear or branched (C1-C6)-alkyl substituted with carboxy-group -CO2H; -residue of the formula: -CH2-CH2X-(CH2-CH2O)nR wherein R has abovementioned values; n means a whole number from 0 to 1 while X represents oxygen atom; -heteroaryl chosen from the group consisting of 2-pyrimidinyl or 4-pyrimidinyl. Also, invention proposes a pharmaceutical composition inhibiting of interleukin-8-induced chemotaxis of neutrophiles and comprising as an active components (R)-enantiomers of 2-arylpropionamides of the formula (I) and their pharmaceutically acceptable salts in mixture with a suitable carrier. Also, invention proposes a method for preparing compounds of the formula (Ia). Also, invention proposes (R)-enantiomers of 2-arylpropionic acids of the formula (Va) given in the invention description and their pharmaceutically acceptable salts. Proposed (R)-2-arylpropionamides are useful in prophylaxis and treatment of tissue damage caused by enhanced accumulation of polymorphonuclear neutrophiles in the inflammation sites.;EFFECT: improved preparing method, valuable medicinal properties of compounds and composition.;13 cl, 6 tbl, 24 ex
机译:领域:本发明涉及式(Ia)的2-芳基丙酰胺的(R)-对映异构体:<图像文件=“ 00000002.GIF” he =“ 22” imgContent =“ undefined“ imgFormat =” GIF“ wi =” 62“ />及其药学上可接受的盐,其中芳基代表被选自异丙基,乙酰基,(2'',6''-二氯苯基)氨基的基团取代的苯基,-羟基异丙基,(R,S)-羟基苄基及其单个R-异构体,(R,S)-(-甲基苄基)及其单个R-异构体和(R,S)-羟基-甲基苄基及其单个R-异构体异构体R代表氢原子(H)或(C 1 -C 4 )-烷基; R'代表下列基团:-由被羧基取代的直链或支链(C 1 -C 6 )-烷基组成的氨基酸残基-CO 2 H; -公式的残基:-CH 2 -CH 2 X-(CH 2 -CH 2 O) nR其中R具有上述值; n是0〜1的整数,X是氧原子。 -杂芳基选自2-嘧啶基或4-嘧啶基。另外,本发明提出了一种抑制白介素8诱导的嗜中性粒细胞趋化性的药物组合物,其包含与合适的载体混合的式(I)的2-芳基丙酰胺的R-对映异构体及其药学上可接受的盐。另外,本发明提出了一种制备式(Ia)化合物的方法。另外,本发明提出了本发明说明书中给出的式(Va)的2-芳基丙酸的(R)-对映异构体及其药学上可接受的盐。拟议的(R)-2-芳基丙酰胺可用于预防和治疗由多形核嗜中性粒细胞在炎症部位的积累增强引起的组织损伤。;效果:改进的制备方法,化合物和组合物的重要药用特性; 13 cl,6 tbl ,24前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号